Close

BofA Securities Downgrades Prelude Therapeutics (PRLD) to Neutral

November 20, 2020 6:04 AM EST Send to a Friend
BofA Securities analyst Tazeen Ahmad downgraded Prelude Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login